000 01299 a2200337 4500
005 20250518024713.0
264 0 _c20200221
008 202002s 0 0 eng d
022 _a1095-8355
024 7 _a10.1002/cbin.11121
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLiu, Qiang
245 0 0 _aThe induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin.
_h[electronic resource]
260 _bCell biology international
_cNov 2019
300 _a1245-1256 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBone Neoplasms
_xmetabolism
650 0 4 _aCell Line, Tumor
650 0 4 _aCisplatin
_xtherapeutic use
650 0 4 _aDrug Resistance, Neoplasm
_xdrug effects
650 0 4 _aFerroptosis
_xdrug effects
650 0 4 _aHumans
650 0 4 _aNF-E2-Related Factor 2
_xmetabolism
650 0 4 _aOsteosarcoma
_xmetabolism
650 0 4 _aPhospholipid Hydroperoxide Glutathione Peroxidase
_xmetabolism
650 0 4 _aPiperazines
_xpharmacology
650 0 4 _aSTAT3 Transcription Factor
_xmetabolism
700 1 _aWang, Kunzheng
773 0 _tCell biology international
_gvol. 43
_gno. 11
_gp. 1245-1256
856 4 0 _uhttps://doi.org/10.1002/cbin.11121
_zAvailable from publisher's website
999 _c29418570
_d29418570